News

​Rigshospitalet's Phase I Unit is heading the world's first trial of new and promising cancer treatment with potential for a major breakthrough within immunotherapy

​​The new hospital wing for children, adolescents and pregnant women at Rigshospitalet, BørneRiget, will have a distinctive characteristic; a building shaped as two hands gathering all children, adolescents and women in labour under one roof while taking care of the whole family.

​New grant of DKK 100 million to promote translation of research results into novel therapies targeting stem cells in blood cancers and diabetes.

​Surprising results from Danish researchers in new diabetes study

​From April 2017 the Australian professor and diabetes expert David McIntyre from the University of Queensland is affiliated with the Center for Pregnant Women with Diabetes at Rigshospitalet. He will investigate options for implementing international guidelines for diagnosing pregnancy-related diabetes in Denmark.

​Horton's disease (cluster headache) is usually considered as a disease found in men. However, research by the Danish Headache Centre shows that women have the same characteristic symptoms and often go misdiagnosed. 

​Children whose mothers have smoked during pregnancy have a weaker retina-brain connection. This is the result of new research by Rigshospitalet, Zealand University Hospital and the University of Copenhagen.

​In a comprehensive study of 1130 Danish boys and 424 Chilean boys, a group of researchers headed by Professor Anders Juul from Rigshospitalet has found two new genes which may help explain why some boys reach puberty later than others.

​Six project teams have submitted their proposals on how the future hospital for children, adolescents and pregnant women at Rigshospitalet should look like.

Canadian Dr. John E. Dick is to receive Rigshospitalet’s International KFJ Award, and part of the honour is for his work in the fight against leukaemia.

​The development of the new children's wing at Rigshospitalet has started long before the construction site is established. As an experiment, the project organisation chose to involve two users in their hiring of a new innovation consultant, to ensure that the users have as much influence as possible.

​A new research programme starting in 2017 will examine how nurses and other health personnel can help people with cancer become more involved in their treatment to improve quality of life.

​Innovation Fund Denmark is investing DKK 25 mill. in new stem-cell treatment for patients suffering from severe heart failure. The treatment has been developed at Rigshospitalet and can reduce waiting times drastically. With this large investment, research and stem cell production are now entering a crucial phase.

Researchers from the Finsen Laboratory and BRIC in collaboration with researchers from Germany and Norway have developed a new computational method for analysis of large data material from thousands of cancer patients. These ‘big data’ can be used to understand how cancer genes are activated which enables targeted therapy especially for patients with aggressive tumours

​Rigshospitalet has examined all the received applications for pre-qualification. Six teams are invited to place a bid. The final winner will be selected during August 2017.

​On 14 October 2016 Rigshospitalet invites you to come join the celebration of Copenhagen Culture Night!

​A simple adjustment to patients' therapeutic regimen may improve the effectiveness of the standard epigenetic treatment for cancers. A pilot clinical trial to test the effectiveness of vitamin C as a booster in regard to myeloid dysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment.

Mikkel-Ole Skjødt has been granted the recognized "Young Investigator Award" for his pioneering work regarding a new immunoregulatory molecule.

​For patients with symptomatic systolic heart failure not caused by coronary artery disease, an implantable cardioverter-defibrillator (ICD) does not benefit the overall survival, according to a study conducted at the University Hospital in Copenhagen, Denmark.

​Neither gay men nor heterosexual people with HIV transmit the virus to their partner, provided they are on suppressive antiretroviral treatment. This has been demonstrated in the results of the world’s largest study of people with HIV who have had condomless sex with their HIV negative partners.

​A randomized clinical trial comparing transcatheter and surgical aortic valve replacement in younger low risk patients with aortic stenosis.

Danish researchers from EDMaRC at Rigshospitalet, Copenhagen are the first to describe a possible epigenetic link between the environment and pubertal timing. To a large extent, pubertal timing is herita​ble, but the underlying genetic causes are still unexplained. Researchers have now studied how chemical modifications of the human genome (so-called epigenetic modifications​) change when girls and boys enter puberty. The results indicate that such epigenetic chang​​es are involved in defining the onset of puberty. 

​The Capital Region of Denmark, Rigshospitalet and Ole Kirk's Foundation have joined forces in a partnership to build a first-rate hospital building that sets new standards for the treatment of children, adolescents, pregnant women and their families. The working title of the construction project is: Children's Hospital Copenhagen.

​An increasing number of young people experience blood clots in the brain. Young males are particularly at risk. This is the result of a new research study from Rigshospitalet. Although the condition is still rare among young people, the results call for a greater focus on young people with regard to prevention and rehabilitation.  

​The incidence of serious viral infections after transplant surgery at Rigshospitalet has plummeted since infection and transplant specialists began using the MATCH database. Odense University Hospital and Aarhus University Hospital are now joining the collaborative work.

​New Intensive Care Department project will use big data to build models to better predict treatment paths and treatment impacts for intensive-care patients.

​​​The Master of Headache Disorders is a new continuing medical education for health care professionals with experience in headache medicine. ​​

​A new study from Rigshospitalet finds that many ultraviolet (UV)-filtering chemicals commonly used in sunscreens interfere with the function of human sperm cells. "These results are of concern and might explain in part why unexplained infertility is so prevalent," said the study's senior investigator, Prof. Niels Skakkebaek, MD, DMSc.

​Over the next two years, parents of all newborns at Rigshospitalet, Herlev Hospital and Hvidovre Hospital will have an option to have their babies' hearts scanned shortly after birth. The option is part of the ”Copenhagen Baby Heart ” research project to provide new knowledge about the heart and heart diseases.

​Following an offer of hitherto unseen accuracy in HIV type determination, a US-headed international research project has chosen the Unit of Genomic Medicine to analyse more than 4,000 samples from patients with HIV.

​Children with acute leukaemia react to chemotherapy in different ways, depending on their ethnic background. Therefore, the search for tailored treatment needs to take into account ethnic gene variants in order to understand the differences in how the body assimilates the toxic medication.

​The Danish Headache Center is among the best in the world within research and treatment of headache disorders. The new centre will be located at Rigshospitalet - Glostrup, and will have plenty of space for treatment of patients as well as for research.

​Research is a precondition for better patient treatment. In rare cases, research also results in a paradigm shift in understanding diseases and the cellular mechanisms behind them.  Such a paradigm shift has been on its way for testicular cancer ever since Niels Skakkebæk from the Department of Growth and Reproduction in 1972 published the first examples of the early stages of testicular cancer (carcinoma in situ) in two patients at Rigshospitalet in the internationally acclaimed journal, The Lancet.

​A group of researchers headed by Niels Behrendt and Lars Engelholm from the Finsen Laboratory and Biotech Research & Innovation Centre (BRIC) have discovered that cells from primary bone cancer degrade bone tissue through a different process than in metastatic bone cancer. By treating the patient with a special antibody, researchers have succeeded in slowing down this process and reducing bone loss by up to 80% in a cancer mouse model.

​Professor Henning Bundgaard has been a pioneer in endeavours to improve treatment of patients with congenital heart diseases in Denmark and to give affected relatives the opportunity to be examined for congenital heart diseases. As a new professor at the University of Copenhagen, Professor Bundgaard will research into better treatment of both adults and children.

​Over the next few years, Professor Lars Søndergaard will launch a number of research projects covering the entire spectrum of congenital heart disease – from the foetal stage and well into adulthood. As Professor Søndergaard said, “Adult patients in particular are unknown territory for researchers". 

New MRI scans show exactly where the Christmas spirit is located in the brain. The new results from a group of researchers at Rigshospitalet were published in the Christmas issue of the prestigious British Medical Journal. 

​The birth rate is declining in all industrialised countries, and socioeconomic factors and women's age are not solely to blame. Male reproductive health and environmental factors are also significant, as concluded in a new scientific review article. The article was recently published in the prestigious American journal Physiological Reviews.

​A research group lead by Dr. Niels Behrendt and Dr. Lars Engelholm from the Finsen Laboratory and BRIC shows that Osteosarcoma cells degrade the bone tissue through a completely different process than metastasised bone cancer. Through treatment with a specific antibody, the researchers blocked the process and reduced up to 80% of bone degradation in a cancer mouse model. 

​Prof. John C. Burnett Jr, cardiologist at Mayo Clinic, Minnesota, USA, has received Rigshospitalet’s International KFJ Award 2015. The award was partly in recognition of his impressive research, publication profile and work within treatment of heart failure and peptide hormones produced by the heart itself. The award was presented at Rigshospitalet and marks the beginning of a new cross-Atlantic cooperation in the field of heart disease, endocrinology, stem cell therapy and diagnostics.​

​​A new study reveals that many European hospitals fail to routinely test people who may be at risk of an HIV-infection. If tests were more widely offered in the healthcare system, fewer HIV-patients would go unnoticed, especially in Northern Europe. 

​Men experiencing stress have significantly impaired semen quality. This has been demonstrated in a major new study by scientists at the Department of Growth and Reproduction and EDMaRC at Rigshospitalet. The study is the largest of its kind and it included 1,215 young Danish men.​

​Two-day meeting will bring greater attention to the science of TB and its implementation

​Researchers from the Danish Multiple Sclerosis Center at Rigshospitalet have discovered that obesity and lack of sunlight in the teenage years can affect the onset of sclerosis later in life. 

​The search to cure malaria in pregnant women has provided an unexpected bonus for Danish researchers; what looks like an effective weapon against cancer. Researchers hope to begin human trials within the next four years.​​

​Professor Anders Juul receives the award from the European Society of Paediatric Endocrinology today during the 54th Annual ESPE conference in Barcelona.